What happened
An Adelaide-led Science Advances review reappraises where cell-free fetal DNA comes from, how it enters maternal blood and whether it travels attached to extracellular vesicles or other structures. The authors argue that better biology could improve non-invasive prenatal testing.
Why it matters
NIPT is widely used because it is safer than invasive procedures for screening, but low fetal fraction, false results and limited scope still matter. This paper is a research agenda, not a new clinical test.
What to watch
Experimental validation, whether fetal-fraction improvements reduce inconclusive results, evidence for broader genetic screening and whether pre-eclampsia prediction becomes clinically useful.
